Comparison of Disease Status and Outcomes of Patients With Psoriatic Arthritis (PSA) Receiving Adalimumab or Etanercept Monotherapy in the United States (US)

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.900
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV